Skip to main content
. 2022 Oct 17;9(2):e002060. doi: 10.1136/openhrt-2022-002060

Table 3.

Lp(a) levels by atherosclerotic disease history

Type of event Patients
N=48 135
Lp(a) mg/dL
Median (IQR)
(n=29 765)
Lp(a) nmol/L
Median (IQR)
(n=18 370)
LDL-C mg/dL
Median (IQR)
(n=47 988)
Cardiovascular history
 MI, n (%) 37 383 (77.7) 18.2 (8.0–58.5) 40.9 (14.8–155.0) 75.0 (58.0–98.0)
 Ischaemic stroke, n (%) 7568 (15.7) 14.3 (7.0–45.8) 41.0 (15.0–150.7) 83.0 (62.0– 112.1)
Any PAD 5925 (12.3)
 Limb artery revascularisation, n (%) 3475 (7.2) 19.6 (7.9–62.9) 54.0 (18.0–175.0) 77.7 (59.0– 102.0)
 Leg amputation, n (%) 421 (0.9) 26.8 (8.6–80.8) 41.1 (18.4–162.3) 78.0 (57.5– 101.0)
 Symptomatic PAD with ABI ≤0.9, n (%) 3557 (7.4) 21.2 (8.0–70.0) 57.3 (17.9–185.0) 83.0 (62.0– 111.0)
Medical history (n=48 135)
 Prior MI, n (%) 35 088 (72.9) 18.2 (8.0–57.9) 40.0 (14.5–152.8) 75.0 (58.0– 97.8)
 Prior ischaemic stroke, n (%) 6037 (12.5) 14.0 (7.0–41.9) 40.0 (15.0–142.0) 85.0 (63.8– 114.0)
 Prior PAD, n (%) 4433 (9.2) 21.0 (8.0–66.5) 50.0 (16.8–171.8) 83.0 (62.0– 110.0)
 Multiple events, n (%) 2577 (5.4) 18.3 (7.7–69.0) 54.3 (16.9–182.0) 76.2 (57.6– 102.5)

P<0.001 compared with patients with history of MI.

ABI, ankle brachial index; LDL-C, low-density lipoprotein cholesterol; Lp(a), lipoprotein(a); MI, myocardial infarction; PAD, peripheral artery disease.